Wedge liver resection as part of cytoreductive surgery in advanced ovarian cancer – a safe and feasible procedure for a gynecologic oncologist

Le résumé fourni par la source

Objective: In this study, we aimed to determine the learning curve for liver wedge resection performed as part of cytoreductive surgery in advanced ovarian malignant tumors. Materials and methods: This was a retrospective analysis of 120 women diagnosed with stage IIIC ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO) classification: 22 underwent liver wedge resection as part of cytoreductive surgery (Group A), while 98 did not require liver surgery (Group B). In the study, the t-Student test was used for variables with normal distribution and the Mann−Whitney U test was utilized for increment and abnormally distributed variables. The variables categorized were shown as a number of cases (n) and a percentage (%), and compared using the chi-square test, with a p-value <0.05 considered significant. A cumulative sum control chart (CUSUM) method was used to investigate the learning curves in both groups and the entire cohort. Results: There were no significant differences in the operating time, intraoperative blood loss, postoperative hospitalization or minor and severe adverse effects between the Groups A and B. The operative time, total blood loss, and incidence of adverse effects showed a similar learning curve for Group B and the entire cohort. Conclusion: It is safe and feasible for gynecologic oncologists to perform wedge liver resections as part of cytoreductive surgery in women with advanced ovarian tumors.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.